MoneyWorks4Me

Abraxis Biosciences files complaint against SPARC in US District Court

21 Aug 2019 Evaluate

Abraxis Biosciences LLC has filed a complaint against Sun Pharma Advanced Research Company (SPARC) in the US District Court for the district of New Jersey. It alleged that the SPARC’s filing of New Drug Application (NDA) for Taclantis injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the Orange Book listed patents for Abraxane.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Peers
Company Name CMP
Sagility 45.94
Prime Focus 352.35
Knowledge RealtyTrt. 113.71
Indegene 596.10
Syngene Internatl. 385.35
View more..